Login to Your Account



Teva Buying HGS Spinout CoGenesys for $400M Cash

By Jennifer Boggs


Wednesday, January 23, 2008
Privately held CoGenesys Inc., a 2006 spinout of Human Genome Sciences Inc., is being acquired by potential collaborator Teva Pharmaceutical Industries Ltd. in a $400 million cash deal. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription